Loading…

Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma

Purpose It has been indicated that activated hepatic stellate cells (HSCs) play key roles on the pathogenesis of hepatocellular carcinoma (HCC). The purpose of the study was to investigate the potential mechanism in it. Methods Activation of HSCs, the expression of myocyte enhancer factor 2 (MEF2),...

Full description

Saved in:
Bibliographic Details
Published in:Journal of cancer research and clinical oncology 2008-01, Vol.134 (1), p.83-91
Main Authors: Bai, XueLi, Wu, LiHua, Liang, TingBo, Liu, ZhiQiang, Li, JunJian, Li, DongLin, Xie, HaiYang, Yin, ShengYong, Yu, Jun, Lin, Qi, Zheng, ShuSen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose It has been indicated that activated hepatic stellate cells (HSCs) play key roles on the pathogenesis of hepatocellular carcinoma (HCC). The purpose of the study was to investigate the potential mechanism in it. Methods Activation of HSCs, the expression of myocyte enhancer factor 2 (MEF2), class II histone deacetylases (II HDACs) and histone acetylation were analyzed in specimens of primary HCCs, cirrhotic and normal livers. Activated HSCs were identified using anti-a-smooth muscle actin (a-SMA) by Immunohistochemistry (IHC). The levels of expression of MEF2A, MEF2C and II HDACs mRNA and protein were measured by real time quantitative PCR and western blot (WB). Histone acetylation was assessed using anti-acetyl-histone H3, -H4 by WB and IHC. A P value 
ISSN:0171-5216
1432-1335
DOI:10.1007/s00432-007-0252-7